Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myria Galazi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 15, 2010
D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic reviewNicolas Galazis, Myria Galazi, William Atiomo
Expert Review of Anticancer Therapy|November 19, 2013
The role of metastasectomy in renal cell carcinomaEleni Josephides, Alejo Rodriguez-Vida, Myria Galazi, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
Drug Design, Development and Therapy|July 15, 2015
Enzalutamide for the treatment of metastatic castration-resistant prostate cancerAlejo Rodriguez-Vida, Myria Galazi, Sarah Rudman, et al.
Expert Review of Anticancer Therapy|January 8, 2014
Cytoreductive nephrectomy: past, present and futureMyria Galazi, Alejo Rodriguez-Vida, Eleni Josephides, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 27, 2013
Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integrationNicolas Galazis, Yik-Lam Pang, Myria Galazi, et al.
BJU International|July 16, 2020
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimenErnese Gjafa, Kenrick Ng, Tami Grunewald, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Cancers|February 13, 2026
Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with <i>PIK3CA</i>-Mutant Metastatic Breast Cancer: A Single-Center Retrospective StudySotiris Loizidis, Damianos Michaelides, Yiola Marcou, et al.
Prostate Cancer and Prostatic Diseases|July 26, 2020
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxisLara Pemberton, Kenrick Ng, Ursula McGovern, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 15, 2010
D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic reviewNicolas Galazis, Myria Galazi, William Atiomo
Expert Review of Anticancer Therapy|November 19, 2013
The role of metastasectomy in renal cell carcinomaEleni Josephides, Alejo Rodriguez-Vida, Myria Galazi, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
Drug Design, Development and Therapy|July 15, 2015
Enzalutamide for the treatment of metastatic castration-resistant prostate cancerAlejo Rodriguez-Vida, Myria Galazi, Sarah Rudman, et al.
Expert Review of Anticancer Therapy|January 8, 2014
Cytoreductive nephrectomy: past, present and futureMyria Galazi, Alejo Rodriguez-Vida, Eleni Josephides, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 27, 2013
Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integrationNicolas Galazis, Yik-Lam Pang, Myria Galazi, et al.
BJU International|July 16, 2020
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimenErnese Gjafa, Kenrick Ng, Tami Grunewald, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Cancers|February 13, 2026
Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with <i>PIK3CA</i>-Mutant Metastatic Breast Cancer: A Single-Center Retrospective StudySotiris Loizidis, Damianos Michaelides, Yiola Marcou, et al.
Prostate Cancer and Prostatic Diseases|July 26, 2020
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxisLara Pemberton, Kenrick Ng, Ursula McGovern, et al.
Pageof 3